Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis
MAA El-Din, KS Hughes, RA Raad, SI Goldberg… - Radiation …, 2009 - Springer
Radiation oncology, 2009•Springer
Background To evaluate diagnosis, management and outcome of breast cancer (BC)
occurring after irradiation for Hodgkin's lymphoma (HL). Methods 39 cases of BC in 28 HL
survivors were retrospectively reviewed. 21 patients were included in a case-control
analysis. Results The median age at diagnosis of HL and BC was 25.3 and 45.3 years,
respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%)
had bilateral disease. Mode of detection of the index breast cancers was by mammographic …
occurring after irradiation for Hodgkin's lymphoma (HL). Methods 39 cases of BC in 28 HL
survivors were retrospectively reviewed. 21 patients were included in a case-control
analysis. Results The median age at diagnosis of HL and BC was 25.3 and 45.3 years,
respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%)
had bilateral disease. Mode of detection of the index breast cancers was by mammographic …
Background
To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL).
Methods
39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis.
Results
The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = .001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < .001 and .003, respectively).
Conclusion
The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果